Indee Labs

Active

Enabling T cell immunotherapy discovery, development and manufacturing

What it does

Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.

Next to it in Healthcare and bio · T cell immunotherapy delivery

Sigma GeneticsY Combinator W17
Sigma Genetics is a biotechnology company that is building…
株式会社BioSerenTachPlug and Play
BioSerenTach Inc delivers antigens directly to Langerhans cells of the immune system.
株式会社メディネットPlug and Play
Cancer immuno-cell therapy is an advanced medical practice.
リバーセル株式会社Plug and Play
Rebirthel is a biotech company, focused on the Development and operationalization of cell-based cancer immunotherapies.
Regcell Co., Ltd.Plug and Play
Regcell is a university-originated venture company and aims to develop novel immunotherapies for immunological diseases and cancer by targeting regulatory T cells, which are specialized for immune suppression.
CyGenica Ltd.SOSV SOSV IndieBio RebelBio 04
Delivering therapeutic molecules directly into living cells
Avro Life ScienceY Combinator W18
Skin patches for generic drug delivery.
Intact TherapeuticsY Combinator W19
Smart gels for local drug delivery to the gut